FDA recall D-0594-2024

Product

Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2

Reason for recall

Subpotent Drug: reduced efficacy for epinephrine

Distribution

Nationwide in the USA

Key facts

Status

Ongoing

Initiation date

2024-07-03

Report date

2024-07-17

Voluntary/Mandated

Voluntary: Firm initiated

Location

Chandler, AZ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0594-2024